Close
Nordic 9Nordic 9

Helicase Venture (investor - Venture Capital)

United States helicaseventure.com
See something wrong or missing? Let us know
Offices:Boston

Helicase Venture is an investment firm focused on healthcare.

Average round investment:20.39M USD
Average number per year:1.0
Distribution: 2022 (1)
Portfolio companies: Austria Ribbon Biolabs
Mostly invests in: Austria Austria (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Helicase Venture

Name Criteria
Germany Simon Capital
71%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Austria
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United Kingdom Lansdowne Partners
71%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Austria
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Austria xista science venture
70%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Austria
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
Hong Kong CR-CP Life Science Fund
70%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Future Ventures
70%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Illumina Ventures
70%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Canada Inovia Capital
70%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Lauxera Capital Partners
70%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland Lichtsteiner Foundation
70%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Nabuboto
70%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top